Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
NHS Blood and Transplant
500 North Bristol Park
Bristol
BS34 7QH
UK
Contact person: Jo Murphy
Telephone: +44 1179212718
E-mail: jo.murphy@nhsbt.nhs.uk
NUTS: UKK11
Internet address(es)
Main address: https://www.nhsbt.nhs.uk/
Address of the buyer profile: https://www.nhsbt.nhs.uk/
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Managed Service Contract for the Bacterial Screening of Platelets
Reference number: C116642
II.1.2) Main CPV code
85111810
II.1.3) Type of contract
Services
II.1.4) Short description
A fully integrated, high throughput, automated bacterial screening system which can detect bacterial contamination in platelet components. The system will be used in Filton (Bristol), Manchester and Colindale (London) where approximately 270,000 adult therapeutic doses of platelets are manufactured each year.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
47 085 000.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
48921000
71900000
38434520
33698100
71632000
71600000
85111810
85146000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
A direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated solution, which includes all the necessary equipment, installation, maintenance, consumables, reagents, software, including an inter-operability provision with NHSBT’s existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below. All invitro diagnostic medical devices, for example, instruments, consumables, and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT’s host IT system (PULSE) without the need for changes to PULSE.<br/><br/>A fully integrated, high throughput, automated bacterial screening system which can detect bacterial contamination in platelet components. The system will be used in Filton (Bristol), Manchester and Colindale (London) where approximately 270,000 adult therapeutic doses of platelets are manufactured each year. The system must be CE/UKCA marked. Additional requirements to be included with the managed service contract include:<br/>- continuous calibrated temperature monitoring<br/>- ability to integrate with NHSBT information management system<br/>- alerting software (for positive results, hardware errors, temperature excursions)<br/>- consumables (including, but not limited to, sterile sampling connecting devices)<br/><br/>All test protocols must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (https://www.transfusionguidelines.org/red-book) and the Good Practice Guidelines for Blood Establishments that are Required to Comply with Directive 2005/62/EC. These are published in the 20th edition of the Guide to the preparation, use and quality assurance of blood components.
II.2.5) Award criteria
Quality criterion: Technical
/ Weighting: 10
Price
/ Weighting:
90
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2023/S 000-005555
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
04/12/2023
V.2.2) Information about tenders
Number of tenders received: 1
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 1
Number of tenders received by electronic means: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Biomerieux UK Limited
Chineham Gate, Crockford Lane
Basingstoke
RG24 8NA
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 47 085 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
The High Court
The Strand
London
WC2A 2LL
UK
Internet address(es)
URL: https://www.judiciary.uk/courts-and-tribunals/high-court/
VI.4.2) Body responsible for mediation procedures
The High Court
The Strand
London
WC2A 2LL
UK
Internet address(es)
URL: https://www.judiciary.uk/courts-and-tribunals/high-court/
VI.4.4) Service from which information about the review procedure may be obtained
NHS Blood and Transplant
500 North Bristol Park
Bristol
BS34 7QH
UK
Internet address(es)
URL: https://www.nhsbt.nhs.uk/
VI.5) Date of dispatch of this notice
06/12/2023